Cite

HARVARD Citation

    Mizutani, K. et al. (2018). Ritanserin, a serotonin-2 receptor antagonist, inhibits functional recovery after cerebral infarction. NeuroReport. 29 (1), p. . [Online]. 
  
Back to record